DE69229857D1 - Zusammensetzung zur verwendung in der transdermalen verabreichung - Google Patents
Zusammensetzung zur verwendung in der transdermalen verabreichungInfo
- Publication number
- DE69229857D1 DE69229857D1 DE69229857T DE69229857T DE69229857D1 DE 69229857 D1 DE69229857 D1 DE 69229857D1 DE 69229857 T DE69229857 T DE 69229857T DE 69229857 T DE69229857 T DE 69229857T DE 69229857 D1 DE69229857 D1 DE 69229857D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- biologically active
- active agent
- transdermal administration
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPK465191 | 1991-02-18 | ||
AUPK784891 | 1991-08-19 | ||
AUPK784791 | 1991-08-19 | ||
AUPK784691 | 1991-08-19 | ||
US07/795,499 US5308621A (en) | 1991-02-18 | 1991-11-21 | Ascorbic acid composition and transdermal administration method |
PCT/AU1992/000058 WO1992014442A1 (en) | 1991-02-18 | 1992-02-18 | Composition for use in transdermal administration |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69229857D1 true DE69229857D1 (de) | 1999-09-30 |
DE69229857T2 DE69229857T2 (de) | 2000-04-20 |
Family
ID=27507420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69229857T Expired - Fee Related DE69229857T2 (de) | 1991-02-18 | 1992-02-18 | Zusammensetzung zur verwendung in der transdermalen verabreichung |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0572494B1 (de) |
JP (1) | JPH06508100A (de) |
AT (1) | ATE183639T1 (de) |
AU (1) | AU668679B2 (de) |
CA (1) | CA2103725C (de) |
DE (1) | DE69229857T2 (de) |
WO (1) | WO1992014442A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0663831A1 (de) * | 1991-12-13 | 1995-07-26 | G.D. Searle & Co. | Azidothymidin zur transdermalen Verabreichung |
DE4329446A1 (de) * | 1993-09-01 | 1995-03-02 | Basf Ag | Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen |
DE4332093C2 (de) * | 1993-09-22 | 1995-07-13 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung |
US6103267A (en) * | 1998-07-27 | 2000-08-15 | Sunsmart, Inc. | Stabilized ascorbic acid, composition, and method of use |
JP2003040763A (ja) * | 2001-05-23 | 2003-02-13 | Taisho Pharmaceut Co Ltd | 多価アルコール含有軟膏剤基剤 |
DE10237057A1 (de) * | 2002-08-09 | 2004-03-25 | Grünenthal GmbH | Opioid-Rezeptor-Antagonisten in Pflasterformulierungen |
DE10261696A1 (de) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
MX354603B (es) | 2007-05-25 | 2018-03-13 | Indivior Uk Ltd | Formulaciones de transferencia sostenida de compuestos de risperidona. |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR751951A (fr) * | 1933-03-02 | 1933-09-13 | Procédé d'hydrophilisation des corps gras | |
FR948326A (fr) * | 1947-06-24 | 1949-07-28 | Brillantine à base d'hormones | |
US4156736A (en) * | 1976-05-28 | 1979-05-29 | Sanol Schwarz-Monheim Gmbh | Supersaturated isosorbide dinitrate solution, process for its production and its use |
GB8629639D0 (en) * | 1986-12-11 | 1987-01-21 | Beecham Group Plc | Composition & method |
GB8401965D0 (en) * | 1984-01-25 | 1984-02-29 | Beecham Group Plc | Composition |
EP0156080B2 (de) * | 1984-03-05 | 1993-10-20 | Nitto Denko Corporation | Haftendes Arzneimittelpräparat für perkutane Absorption |
US4573995A (en) * | 1984-10-09 | 1986-03-04 | Alza Corporation | Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine |
JPH066534B2 (ja) * | 1986-10-09 | 1994-01-26 | 積水化学工業株式会社 | 経皮吸収貼付剤 |
GB8629640D0 (en) * | 1986-12-11 | 1987-01-21 | Beecham Group Plc | Composition & method |
US5110606A (en) * | 1990-11-13 | 1992-05-05 | Affinity Biotech, Inc. | Non-aqueous microemulsions for drug delivery |
-
1992
- 1992-02-18 WO PCT/AU1992/000058 patent/WO1992014442A1/en active IP Right Grant
- 1992-02-18 CA CA002103725A patent/CA2103725C/en not_active Expired - Fee Related
- 1992-02-18 AU AU12723/92A patent/AU668679B2/en not_active Ceased
- 1992-02-18 JP JP4504787A patent/JPH06508100A/ja active Pending
- 1992-02-18 EP EP92905485A patent/EP0572494B1/de not_active Expired - Lifetime
- 1992-02-18 DE DE69229857T patent/DE69229857T2/de not_active Expired - Fee Related
- 1992-02-18 AT AT92905485T patent/ATE183639T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU668679B2 (en) | 1996-05-16 |
DE69229857T2 (de) | 2000-04-20 |
EP0572494B1 (de) | 1999-08-25 |
CA2103725A1 (en) | 1992-08-19 |
EP0572494A4 (en) | 1996-05-29 |
EP0572494A1 (de) | 1993-12-08 |
AU1272392A (en) | 1992-09-15 |
JPH06508100A (ja) | 1994-09-14 |
ATE183639T1 (de) | 1999-09-15 |
CA2103725C (en) | 2002-06-04 |
WO1992014442A1 (en) | 1992-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69229857D1 (de) | Zusammensetzung zur verwendung in der transdermalen verabreichung | |
ATE56869T1 (de) | Lang wirksame cefaclor-formulierung und deren herstellung. | |
MY125556A (en) | Aqueous formulations of peptide | |
YU98792A (sh) | Postupci za dobijanje visokodoznih preparata kolagenaze | |
NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
DE68921814D1 (de) | VIP-Konjugate und deren aktive Fragmente mit hydrophoben Anteilen und topische Zuberetungen zur Verwendung in der Behandlung männlicher Impotenz. | |
DE68919358D1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
PH22556A (en) | Heterocyclic compounds, pharmaceutical compositions containing the same and method of use thereof | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
ATA186692A (de) | Pharmazeutische zusammensetzung | |
SG46307A1 (en) | New pyrazine derivatives the preparation and use thereof | |
PH23003A (en) | Piroxicam monohydrate and aqueous pharmaceutical formulations containing same | |
EP0173664A3 (de) | Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung | |
SE8804628D0 (sv) | New compounds | |
SE8600496L (sv) | Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider | |
DK78487A (da) | Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale | |
ATE238063T1 (de) | Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor | |
Iwata et al. | Interaction between thymopoietin and facteur thymique serique in the rosette inhibition assay | |
FR2684878B1 (fr) | Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation. | |
DK0741579T3 (da) | Vandig formulering med forhalet frigivelse | |
KR900017599A (ko) | 종양 치료용 약학 조성물 | |
ATE53024T1 (de) | Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE102934T1 (de) | Fluorierte flavon-essigsaeure. | |
DE69004882D1 (de) | Flüssige Nitrofurantoinsuspension. | |
SE8604780D0 (sv) | Nikotinkompositioner for att minska obehagseffekter vid nikotinadministration och for att oka hallbarheten pa nikotinberedningar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: TRANSDERMAL TECHNOLOGIES PTY LTD., LAURIETON, NEW |
|
8339 | Ceased/non-payment of the annual fee |